New brain monitoring method may predict injury in tiniest newborns

NCT ID NCT02814383

Completed Knowledge-focused Sponsor: Baylor College of Medicine Source: ClinicalTrials.gov ↗

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study investigates whether a non-invasive brain monitoring tool can predict brain injury in extremely low birth weight infants (≤1000 grams) during their first week of life. Researchers will measure brain blood flow using ultrasound and other sensors to see if changes in perfusion signal risk for conditions like intraventricular hemorrhage. The goal is to develop an early warning system that could guide care and prevent lasting damage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could lead to a monitoring system that helps doctors detect and prevent brain injury in premature infants before it becomes irreversible.
What could go wrong: This is an observational study focused on understanding physiology, not testing a treatment. It is small (70 infants) and early-stage, so it may not directly change care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain injury periventricular leukomalacia Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN INJURY EXTREME PREMATURITY INTRAVENTRICULAR HEMORRHAGE PERIVENTRICULAR LEUKOMALACIA

Contacts and locations

Locations

Baylor College of Medicine

Houston, Texas, 77030, United States
Texas Children's Hospital

Houston, Texas, 77030, United States
Texas Children's Pavilion for Women

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.